Identification |
Name: | D-Phenylalaninamide,N-[(2E)-5-amino-5-methyl-1-oxo-2-hexen-1-yl]-N-methyl-3-(2-naphthalenyl)-D-alanyl-N,Na-dimethyl- |
Synonyms: | D-Phenylalaninamide,N-[(2E)-5-amino-5-methyl-1-oxo-2-hexenyl]-N-methyl-3-(2-naphthalenyl)-D-alanyl-N,Na-dimethyl- (9CI); NN 703; NNC26-0703; Tabimorelin |
CAS: | 193079-69-5 |
Molecular Formula: | C32H40 N4 O3 |
Molecular Weight: | 0 |
InChI: | InChI=1/C32H40N4O3/c1-32(2,33)19-11-16-29(37)35(4)28(22-24-17-18-25-14-9-10-15-26(25)20-24)31(39)36(5)27(30(38)34-3)21-23-12-7-6-8-13-23/h6-18,20,27-28H,19,21-22,33H2,1-5H3,(H,34,38)/b16-11+/t27-,28-/m1/s1 |
Molecular Structure: |
|
Properties |
Flash Point: | 434.2°C |
Boiling Point: | 794.4°Cat760mmHg |
Density: | 1.146g/cm3 |
Refractive index: | 1.6 |
Biological Activity: | Potent, orally active ghrelin receptor (GHS-R1a) agonist (K i = 50 nM at human recombinant GHS-R1a). Stimulates GH release from rat pituitary cells with an EC 50 value of 2.7 nM. Induces hyperphagia and adiposity in lean rats, but not in leptin signaling-deficient ZDF rats. |
Flash Point: | 434.2°C |
Safety Data |
|
|